The fate of 14C-radiolabelled diclofenac and 4'-hydroxydiclofenac in membrane bioreactor treatment of wastewater.


This study aimed at enhancing knowledge on the fate of diclofenac (DF), together with its main human metabolite 4'-hydroxydiclofenac (4'OHDF), during wastewater treatment by using a laboratory-scale membrane bioreactor (MBR). The reactor was fed continuously with non-radiolabelled diclofenac for a one month period prior to a single pulse of a 14C… (More)


  • Presentations referencing similar topics